Expression profiles of craniosynostosis-derived fibroblasts

Molecular Medicine

Volumn 8, Issue 10, 2002, Pages 638-644

  Carinci, Francesco ^a   Bodo, Maria ^b,g   Tosi, Lara ^c,d   Francioso, Francesca ^d   Evangelisti, Rita ^a   Pezzetti, Furio ^c,d   Scapoli, Luca ^a,c   Martinelli, Marcella ^a   Baroni, Tiziano ^b   Stabellini, Giordano ^e   Carinci, Paolo ^c,d   Bellucci, Catia ^b   Lilli, Cinzia ^b   Volinia, Stefano ^a,f  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c CARISBO Foundation   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^g Sezione Istol ed Embriol Sperim   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR RECEPTOR; GENOMIC DNA;

ACROCEPHALOSYNDACTYLY; ARTICLE; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; CROUZON SYNDROME; DNA MICROARRAY; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL;

EID: 0036821229     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402174     Document Type: Article

References (35)

1. Avantaggiato A, Carinci F, Curioni C. (1996) Apert's syndrome: cephalometric evaluation and considerations on pathogenesis. J. Craniofacial Surg. 7: 23-31.
2. Carinci F, Avantaggiato A, Curioni C. (1994) Crouzon syndrome: cephalometric analysis and evaluation of pathogenesis. Cleft Palate Craniofac. J. 31: 201-209.
3. Bodo M, Carinci F, Baroni T, et al. (1996) Effect of interleukins on Crouzon fibroblast phenotype in vitro. Release of cytokines and IL-6 mRNA expression. Cytokine 8: 772-783.
4. Bodo M, Carinci F, Baroni T, et al. (1997) Apert's syndrome: differential in vitro production of matrix macromolecules and its regulation by interleukins. Eur. J. Clin. Invest. 27: 36-42.
5. Bodo M, Carinci F, Baroni T, et al. (1998) Interleukin pattern of Apert fibroblasts in vitro. Eur. J. Cell Biol. 75: 383-388.
6. Bodo M, Baroni T, Carinci F, et al. (1999) A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patient with Crouzon's syndrome. Eur. J. Cell Biol. 78: 323-330.
7. Bodo M, Baroni T, Carinci F, et al. (2000) Interleukin secretion, proteoglycans and procollagen-1(I) gene expression in Crouzon fibroblasts treated with basic fibroblast growth factor. Cytokine 12: 280-283.
8. Locci P, Baroni T, Pezzetti F, et al. (1999) Differential in vitro phenotype pattern TGFB1 activity and TGFB1 mRNA expression in Apert osteoblast. Cell Tissue Res. 279: 475-483.
9. Bodo M, Lilli C, Aisa MC, et al. (2002) Basic fibroblast growth factor: effects on matrix remodeling, receptor expression and transduction pathway in human periosteal fibroblasts with FGFR2 gene mutation. J. Interferon Cytokine Res. 22: 621-630.
10. Naski MC, Ornitz DM. (1998) FGF signaling in skeletal development. Front. Biosci. 3: 781-794.
11. Mansukhani A, Bellosta P, Sahni M, Basilico C. (2000) Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Cell Biol. 149: 1297-308.
12. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S. (1994) Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat. Genet. 8: 98-103.
13. Jabs EW, Li X, Scott AF, et al. (1994) Jackson-Weiss and Crouzon syndrome are allelic with mutations in fibroblast growth factor receptor 2. Nat. Genet. 8: 275-279.
14. Wilkie AOM, Slaney SF, Oldridge M, et al. (1995) Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9: 165-172.
15. Wilkie AO, Morris-Kay GM. (2001) Genetics of craniofacial development and malformation. Nat. Rev. Genet. 2: 458-468 (review).
16. Lajeunie E, Catala M, Renier D. (1999) Craniosynostosis: from a clinical description to an understanding of bone formation of the skull. Childs Nerv. Syst. 15: 676-680.
17. Francioso F, Carinci F, Tosi L, et al. (2002) Identification of differentially expressed genes in human salivary gland tumors by DNA microarrays. Molecular Cancer Therapeutics. 1: 533-538.
18. Storey JD, Tibshirani R. (2001) Estimating the positive false discovery rate under dependence, with applications to DNA microarrays. Technical report number 2001-28, Stanford, CA: Department of Statistics, Stanford University.
19. Webster MK, Donoghue DJ. (1997) FGFR activation in skeletal disorders: too much of a good thing. Trends Genet. 13: 178-182.
20. Gorry MC, Preston RA, White GJ, et al. (1995) Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum. Mol. Genet. 4: 1387-1390.
21. De Risi J, Penland L, Brown P, et al. (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14: 457-460.
22. Dell'Era P, Coco L, Ronca R, Sennino B, Presta M. (2002) Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. Oncogene 21: 2433-2440.
23. Bittner M, Meltzer P, Chen Y, et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406: 536-540.
24. Kahn J, Simon R, Bittner M, et al. (1998) Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 58: 5009-5013.
25. Schaub R, Dupont B, Roodman GD, Leach RJ, Reddy SV. (2000) Assignment of OSTF1 to human chromosome bands 12q24.1→q24.2 by in situ hybridization. Cytogenet. Cell. Genet. 88: 87-88.
26. McPherron AC, Lawler AM, Lee SJ. (1999) Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat. Genet. 22: 260-264.
27. Volinia S, Patracchini P, Otsu M, et al. (1992) Chromosomal localization of human p85-alpha, a subunit of phosphatidylinositol 3-kinase, and its homologue p85-beta. Oncogene 7: 789-793.
28. Berchtold MW, Egli R, Rhyner JA, Hameister H, Strehler EE. (1993) Localization of the human bona fide calmodulin genes CALM1, CALM2, and CALM3 to chromosomes 14q24-q31, 2p21.1-p21.3, and 19q13.2-q13.3. Genomics 16: 461-465.
29. Morris CM, Bodger MP. (1993) Localization of the human poly(A)-binding protein gene (PAB1) to chromosomal regions 3q22-q25, 12q13-q14, and 13q12-q13 by in situ hybridization. Genomics 15: 209-211.
30. Claret FX, Hibi M, Dhut S, Toda T, Karin M. (1996) A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383: 453-457.
31. Liu M, Xie Z, Price DH. (1998) A human RNA polymerase II transcription termination factor is a SWI2/SNF2 family member. J. Biol. Chem. 273: 25541-25544.
32. Ogawa K, Tashima M, Yumoto Y, et al. (1990) Coding sequence of human placenta cofilin cDNA. Nucleic Adds Res. 18: 7169.
33. Goldschmidt-Clermont PJ, Janmey PA. (1991) Profilin, a weak CAP for actin and RAS. Cell 66: 419-421.
34. Carinci P, Becchetti E, Bodo M. (2000) Role of the extracellular matrix and growth factors in skull morphogenesis and in the pathogenesis of craniosynostosis. Int. J. Dev. Biol. 44: 715-723.
35. Arena N, Venti G, Becchetti E, et al. (1991) Characterization of the cytoskeleton in human normal and otosclerotic osteoblast-like cells. Acta Anat. 141: 311-315.